Course of psychiatric symptoms and global cognition in early Parkinson disease
- 16 September 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 83 (12) , 1096-1103
Abstract
Objective: To evaluate the course and predictors of neuropsychiatric symptoms (NPS) and cognition in patients with de novo Parkinson disease (PD). Methods: Cross-sectional study of the cohort of de novo, untreated (at enrollment) patients with PD and healthy controls (HCs) from the Parkinson9s Progression Markers Initiative. Participants have serial assessments of global cognition and symptoms of depression, anxiety, psychosis, impulse control disorders (ICDs), sleep and wakefulness, apathy, and fatigue. Available data up to 24 months of follow-up were included. Results: The available sample size was as follows: baseline (PD = 423, HCs = 196), 12 months (PD = 261, HCs = 145), and 24 months (PD = 96, HCs = 83). Patients with PD experienced more depression, fatigue, apathy, and anxiety than HCs at all time points, and apathy (p = 0.001) and psychosis (p = 0.003) increased over time in patients with PD. Approximately two-thirds of patients with PD who screened positive for depression at any given visit were not taking an antidepressant. The Montreal Cognitive Assessment score decreased significantly over time in patients with PD (p < 0.001), but the change was comparable to that in HCs. At the 24-month visit, 44% of patients had been on dopamine replacement therapy (DRT) for at least 1 year, and this group reported more incident ICDs (p = 0.009) and excessive daytime sleepiness (p = 0.03). Conclusion: Multiple NPS are more common in de novo, untreated patients with PD compared with the general population, but they also remain relatively stable in early disease, while global cognition slightly deteriorates. In contrast, initiation of DRT is associated with increasing frequency of several other NPS.Keywords
This publication has 39 references indexed in Scilit:
- Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: A population‐based studyAnnals of Neurology, 2011
- The natural history of treated Parkinson's disease in an incident, community based cohortJournal of Neurology, Neurosurgery & Psychiatry, 2011
- The MoCANeurology, 2010
- Mild cognitive impairment in Parkinson diseaseNeurology, 2010
- The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2009
- Validation of the questionnaire for impulsive‐compulsive disorders in Parkinson's diseaseMovement Disorders, 2009
- The impact of depressive symptoms in early Parkinson diseaseNeurology, 2007
- Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodiesJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Changes in motor subtype and risk for incident dementia in Parkinson's diseaseMovement Disorders, 2006
- Neuropsychiatric Complications of Medical and Surgical Therapies for Parkinson’s DiseaseJournal of Geriatric Psychiatry and Neurology, 2004